Research and Development grant cheat sheet

• Provides small/medium businesses, entrepreneurs and researchers with access to expert advice and funding to help get a novel product, process or service to market.

• Provides funding to organisations to engage in research on new technologies and economic, commercial and social transformation which support the development of research outcomes that benefit industry partners in the Industrial Transformation Priorities.

• From $50,000.00 to $300,000.00
• Supports the development of long-term strategic research alliances between higher education and industry in order to apply advanced knowledge to problems
  
• Provides opportunities for internationally competitive research projects to be conducted in collaboration with organisations outside the higher education sector
• Enhances the scale and focus of research in Australian Government priority areas.  

• Funds and nurtures early-stage health and medical research to reach proof-of-concept with the potential to attract further capital and support. Research will have secured at least matched

• Drives discoveries that address key health challenges towards proof-of-concept and commercialisation, maximising entrepreneurship and idea potential.
  
  
• The medical device to be developed will be a physical device that is a smart monitoring device, diagnostic, personalised implant or a bionics device with a minimum classification of Class IIa as per TGA guidelines.

• Working with healthcare providers and industry to identify problems and connect them with expertise to solve them. Submissions for emerging digital health solutions through the idea submission process.

• Matched funding between $100,000 and $3 million.
• Supports short-term (up to 3 years), industry-led collaborations. 

Projects must:

• develop a product, service or process that will solve problems for industry and deliver real outcomes
• benefit small to medium enterprises (SMEs)
• include education and training activities.

• Up to 50% of grant project costs for up to 10 years.
• A collaboration between at least 1 Australian industry organisation and 1 Australian research organisation.

Projects must:

• aim to solve industry identified problems and improve the competitiveness, productivity and sustainability of Australian industries
• include an industry-focused education and training program, including a PhD program that builds capability and capacity
• increase research and development (R&D) capacity in small to medium enterprises (SMEs)
• encourage industry take up of research

• Identifies innovative medical devices that will support early clinical innovations and generate commercial returns.
• Offers financial assistance, educational support and infrastructure access to Australian SMEs supporting early clinical development

• A service under the AusIndustry Entrepreneurs' Programme that provides you with advice and funding to get research projects underway in your business.
  
  
• An independent facilitator will make recommendations for your research project, connect you with research institutions and help you apply for a grant to fund your researchers.

• Designed to accelerate the commercialisation of research products that address the impacts of COVID-19 by businesses in partnership with universities and CSIRO in NSW.

• Supports great medical discoveries and promotes opportunities for active clinical researchers to work in partnership with professional colleges and industry.

• Funding opportunities align with the 6 national manufacturing priorities: Medical Products National Manufacturing Priority is key.

• Funding between $1 million to $20 million, up to 50% of the eligible project expenditure.
• Supports projects that integrate Australian businesses into domestic and international value chains which will propel their goods and services into new markets.
• Provides co-funding to encourage linkages between local businesses and domestic and international firms. It will also facilitate the adoption of product standards and greater knowledge sharing.
  

Incorporates 3 activities:

• Early Stage Translation and Commercialisation Support, which funds support for early stage Australian medical research and medical innovation projects with commercial potential.
• Biomedical Translation Bridge, which funds and nurtures early-stage health and medical research to reach proof-of-concept with the potential to attract further capital and support. Research will have secured at least matched funding from third-party sponsorship or co-investment.
• BioMedTech Horizons, which funds innovative and collaborative health technologies. Drives discoveries that address key health challenges towards proof-of-concept and commercialisation, maximising entrepreneurship and idea potential.

• Designed for pre-revenue technology startups to help engage with a potential business customer, or channel to market, to achieve market validation and first sale. Available to pre-revenue technology startups for the development of scalable technology solutions.

• Aims to support early-stage health and medical research and innovation in Australia through to proof-of-concept and beyond, providing opportunities for commercialisation.
• Responsible for managing a $40m portion of this fund, dedicated to supporting novel therapeutics and preclinical medical research.

• Provides support funding for start-ups, scaleups or small and medium enterprises (SMEs) to collaborate with publicly funded research organisations (PFRO), including CSIRO.
  
  
• Aims to accelerate commercialisation of innovative R&D products and services that address the many disruptions caused by the COVID-19 pandemic.  This is wide varying and can be as novel as you like.

• Supports and facilitates researcher and SME access to a diverse range of Australian translational medical research capabilities. One specific mechanism, providing rapid, entry level access is via a voucher-style scheme - the Pipeline Accelerator.

Research and Development Tax Incentive (R&DTI)

• A tax offset for companies conducting eligible R&D activities. Encourages investment in R&D to help your company grow and innovate
  
• As well as providing financial support, the R&DTI can be an opportunity to collaborate with registered Research Service Providers (RSPs).

• Between $200,000 - $750,000
  
• Supports eligible organisations develop innovative preventative, diagnostic, therapeutic and/or disease management products/solutions for identified priorities associated with diabetes and cardiovascular disease.